创胜集团-B(06628)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

06628 创胜集团-B

圣诞节休市 12-24 12:08:22

2.170

-0.080

-3.56%

最高2.300	最低2.120	成交量35.20万
今开2.300	昨收2.250	日振幅8.00%
总市值9.77亿	流通市值9.77亿	总股本4.50亿
成交额77.05万	换手率0.08%	流通股本4.50亿
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

免责声明:香港交易所资讯服务有限公司、其控股公司及／或该等控股公司的任何附属公司均竭力确保所提供信息的准确和可靠度，但不能保证其绝对准确和可靠，且亦不会承担因任何不准确或遗漏而引起的任何损失或损害的责任（不管是否侵权法下的责任或合约责任又或其它责任）

{"stockData":{"symbol":"06628","market":"HK","secType":"STK","nameCN":"创胜集团-B","latestPrice":2.17,"timestamp":1766549302772,"preClose":2.25,"halted":0,"volume":352000,"delay":0,"floatShares":450000000,"shares":450000000,"eps":-0.7956770210813628,"marketStatus":"圣诞节休市","change":-0.08,"latestTime":"12-24 12:08:22","open":2.3,"high":2.3,"low":2.12,"amount":770500,"amplitude":0.08,"askPrice":2.17,"askSize":13500,"bidPrice":2.14,"bidSize":11000,"shortable":0,"etf":0,"ttmEps":-0.7288899062964146,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1766971800000},"marketStatusCode":7,"adr":0,"listingDate":1632844800000,"exchange":"SEHK","adjPreClose":2.25,"openAndCloseTimeList":[[1766539800000,1766548800000]],"volumeRatio":0.615481,"lotSize":500,"spreadScale":0,"tradeCurrency":"HKD"},"requestUrl":"/m/hq/s/06628","defaultTab":"news","newsList":[{"id":"2593742719","title":"创胜集团-B盘中异动 早盘股价大跌5.78%报2.120港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2593742719","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2593742719?lang=zh_cn&edition=full","pubTime":"2025-12-24 09:59","pubTimestamp":1766541585,"startTime":"0","endTime":"0","summary":"2025年12月24日早盘09时59分，创胜集团-B股票出现异动，股价快速跳水5.78%。截至发稿，该股报2.120港元/股，成交量25.3万股，换手率0.06%，振幅8.00%。资金方面，该股资金流入23.4825万港元，流出31.9795万港元。创胜集团-B股票所在的生物技术行业中，整体涨幅为0.37%。创胜集团-B公司简介：创胜集团医药有限公司是一家从事临床阶段生物制药的发现、研究、开发、制造和业务拓展的中国投资控股公司。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251224095945953b95e0&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251224095945953b95e0&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","06628"],"gpt_icon":0},{"id":"2593481246","title":"董事会主席钱雪明增持创胜集团(06628)1万股 每股作价约2.14港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2593481246","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2593481246?lang=zh_cn&edition=full","pubTime":"2025-12-22 19:12","pubTimestamp":1766401939,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，香港联交所最新数据显示，12月18日，董事会主席钱雪明增持创胜集团(06628)1万股，每股作价2.1435港元，总金额约为2.14万港元。增持后最新持股数目为3803万股，持股比例为8.4%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1384532.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1161","06628"],"gpt_icon":0},{"id":"2593483005","title":"创胜集团-B12月22日获主力加仓40.6万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2593483005","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2593483005?lang=zh_cn&edition=full","pubTime":"2025-12-22 16:16","pubTimestamp":1766391365,"startTime":"0","endTime":"0","summary":"12月22日，创胜集团-B股价收平报2.20元，成交金额407.2万元，换手率0.42%，振幅9.55%，量比1.49。创胜集团-B今日主力资金净流入40.6万元，上一交易日主力净流入51.9万元。该股近5个交易日下跌6.38%，主力资金累计净流入117.5万元；近20日主力资金累计净流入87.8万元，其中净流入天数为7日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251222162410a6c08e3f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251222162410a6c08e3f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","06628"],"gpt_icon":0},{"id":"2592030151","title":"创胜集团-B12月19日主力净流入51.9万元 散户资金抛售","url":"https://stock-news.laohu8.com/highlight/detail?id=2592030151","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2592030151?lang=zh_cn&edition=full","pubTime":"2025-12-19 16:15","pubTimestamp":1766132125,"startTime":"0","endTime":"0","summary":"12月19日, 创胜集团-B股价涨2.33%，报收2.20元，成交金额251.9万元，换手率0.25%，振幅4.19%，量比1.02。创胜集团-B今日主力资金净流入51.9万元，上一交易日主力净流出0万元。该股近5个交易日下跌17.56%，主力资金累计净流出15.6万元；近20日主力资金累计净流入75.0万元，其中净流入天数为7日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251219161646a45f1f37&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251219161646a45f1f37&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","06628"],"gpt_icon":0},{"id":"2591608393","title":"创胜集团-B大跌10.31% 近日公布osemitamab三联疗法一线治疗胃或胃食管结","url":"https://stock-news.laohu8.com/highlight/detail?id=2591608393","media":"港美通","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2591608393?lang=zh_cn&edition=full","pubTime":"2025-12-15 14:39","pubTimestamp":1765780753,"startTime":"0","endTime":"0","summary":"12月15日14:26，创胜集团-B股价大幅下跌10.31%。消息面上，近日创胜集团公布osemitamab联合纳武利尤单抗与CAPOX作为胃或胃食管结合部腺癌一线治疗的I/II期临床试验G队列基于CLDN18.2和PD-L1表达的更新疗效分析。新分析结果进一步印证了osemitamab三联疗法所展现的令人鼓舞的临床获益。值得关注的是，在PD-L1 CPS<1和≥1两个亚组中，CLDN18.2较高表达患者的PFS均优于较低表达患者，这表明osemitamab的潜在治疗获益不受PD-L1表达水平影响，具有一致性。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251215144023a6a3e6f6&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251215144023a6a3e6f6&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["06628","BK1161"],"gpt_icon":0},{"id":"2589747332","title":"创胜集团-B12月08日主力净流入46.9万元 散户资金抛售","url":"https://stock-news.laohu8.com/highlight/detail?id=2589747332","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2589747332?lang=zh_cn&edition=full","pubTime":"2025-12-08 16:15","pubTimestamp":1765181731,"startTime":"0","endTime":"0","summary":"12月08日，创胜集团-B股价收平报2.70元，成交金额187.1万元，换手率0.15%，振幅5.93%，量比0.96。创胜集团-B今日主力资金净流入46.9万元，上一交易日主力净流出20.9万元。该股近5个交易日上涨1.50%，主力资金累计净流入47.8万元，其中1个交易日为股价下跌时净流入；近20日主力资金累计净流出14.8万元，其中净流出天数为4日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025120816173697960a84&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025120816173697960a84&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","06628"],"gpt_icon":0},{"id":"1143104292","title":"创胜集团-B在亚太肿瘤大会上发布了Osemitamab联合Nivolumab和Capox治疗一线G/Gej癌症的Transtar102 I/I期试验更新疗效数据","url":"https://stock-news.laohu8.com/highlight/detail?id=1143104292","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1143104292?lang=zh_cn&edition=full","pubTime":"2025-12-05 09:01","pubTimestamp":1764896471,"startTime":"0","endTime":"0","summary":"创胜集团-B在亚太肿瘤大会上发布了Osemitamab联合Nivolumab和Capox治疗一线G/Gej癌症的Transtar102 I/I期试验更新疗效数据","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["06628","BK1161"],"gpt_icon":0},{"id":"2589858430","title":"创胜集团-B(06628)：创胜医药于ESMO Asia公布osemitamab三联疗法一线治疗胃或胃食管结合部腺癌的I/II期(Transtar102)更新疗效数据","url":"https://stock-news.laohu8.com/highlight/detail?id=2589858430","media":"智通财经网","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2589858430?lang=zh_cn&edition=full","pubTime":"2025-12-05 06:25","pubTimestamp":1764887126,"startTime":"0","endTime":"0","summary":"创胜集团-B(06628)发布公告，公司董事会欣然宣布，osemitamab联合纳武利尤单抗与CAPOX作为胃或胃食管结合部腺癌(TranStar102)一线治疗的I/II期临床试验(Transtar102)G \n队列基于CLDN18.2和PD-L1表达的更新疗效分析。该研究结果以壁报形式(摘要编号：#299P)亮相于在新加坡举行的欧洲肿瘤内科学会亚洲年会(ESMO \nAsia Congress 2025)。","market":"sh","thumbnail":"https://img.zhitongcaijing.com/gonggao/ztcj_announce_12.jpeg?x-oss-process=image/format,jpg/quality,Q_80/resize,w_250","type":0,"news_type":0,"thumbnails":["https://img.zhitongcaijing.com/gonggao/ztcj_announce_12.jpeg?x-oss-process=image/format,jpg/quality,Q_80/resize,w_250"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1377938.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"highlight_zhitongcaijin","symbols":["BK1574","BK1515","09939","159938","BK1161","06628"],"gpt_icon":0},{"id":"1147375931","title":"创胜集团医药（6628）发布2025年11月股份变动月报，股本结构无变化","url":"https://stock-news.laohu8.com/highlight/detail?id=1147375931","media":"公告速递","labels":["shareholding","SGX"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1147375931?lang=zh_cn&edition=full","pubTime":"2025-12-04 17:14","pubTimestamp":1764839643,"startTime":"0","endTime":"0","summary":"创胜集团医药有限公司于2025年12月4日披露2025年11月股份变动月报，报告期截至2025年11月30日。公告显示，公司注册股本维持10,000,000,000股，面值每股0.0001美元，总额1,000,000美元。期末已发行股份为449,892,499股，库藏股数量2,516,500股，合计452,408,999股，与上月底持平。不存在新增发行、购回或注销股份情形。公司确认已遵守香港联合交易所有限公司上市规则及相关法律要求。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["06628"],"gpt_icon":0},{"id":"2586424050","title":"董事会主席钱雪明增持创胜集团(06628)2万股 每股作价2.5港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2586424050","media":"智通财经网","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2586424050?lang=zh_cn&edition=full","pubTime":"2025-11-25 18:42","pubTimestamp":1764067374,"startTime":"0","endTime":"0","summary":"香港联交所最新数据显示，11月24日，董事会主席钱雪明增持创胜集团(06628)2万股，每股作价2.5港元，总金额为5万港元。","market":"fut","thumbnail":"https://img.zhitongcaijing.com/image/20251125/20251125184313_51122.png?x-oss-process=image/format,jpg/quality,Q_80/resize,w_250","type":0,"news_type":0,"thumbnails":["https://img.zhitongcaijing.com/image/20251125/20251125184313_51122.png?x-oss-process=image/format,jpg/quality,Q_80/resize,w_250"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1373423.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"highlight_zhitongcaijin","symbols":["06628","BK1161"],"gpt_icon":0},{"id":"2585447450","title":"创胜集团-B11月24日主力净流入27.8万元 散户资金抛售","url":"https://stock-news.laohu8.com/highlight/detail?id=2585447450","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2585447450?lang=zh_cn&edition=full","pubTime":"2025-11-24 16:16","pubTimestamp":1763972160,"startTime":"0","endTime":"0","summary":"11月24日，创胜集团-B股价收平报2.62元，成交金额478.6万元，换手率0.41%，振幅7.25%，量比1.65。创胜集团-B今日主力资金净流入27.8万元，上一交易日主力净流出92.6万元。该股近5个交易日下跌7.09%，主力资金累计净流出64.8万元；近20日主力资金累计净流出75.1万元，其中净流出天数为7日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025112416225095171506&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025112416225095171506&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","06628"],"gpt_icon":0},{"id":"2585672199","title":"创胜集团-B盘中异动 大幅下跌5.24%报2.710港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2585672199","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2585672199?lang=zh_cn&edition=full","pubTime":"2025-11-21 10:44","pubTimestamp":1763693094,"startTime":"0","endTime":"0","summary":"2025年11月21日早盘10时44分，创胜集团-B股票出现异动，股价快速下跌5.24%。截至发稿，该股报2.710港元/股，成交量53.7万股，换手率0.12%，振幅5.24%。资金方面，该股资金流入14.552万港元，流出108.591万港元。创胜集团-B股票所在的生物技术行业中，整体跌幅为4.83%。其相关个股中，帝王国际投资、派格生物医药-B、盛禾生物-B涨幅较大，振幅较大的相关个股有华康生物医学、百奥赛图-B、加科思-B，振幅分别为12.50%、12.06%、11.73%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251121104454a4b07c3a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251121104454a4b07c3a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["06628","BK1161"],"gpt_icon":0},{"id":"2584012139","title":"创胜集团-B(06628)授出20万股奖励股份及80万份购股权","url":"https://stock-news.laohu8.com/highlight/detail?id=2584012139","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2584012139?lang=zh_cn&edition=full","pubTime":"2025-11-20 20:40","pubTimestamp":1763642441,"startTime":"0","endTime":"0","summary":"智通财经APP讯，创胜集团-B(06628)发布公告，于2025年11月20日，公司根据股份激励计划向1名奖励承授人授出20万股奖励股份及根据股份激励计划向2名购股权承授人授出80万份购股权。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1371770.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["06628","BK1161"],"gpt_icon":0},{"id":"2584906932","title":"创胜集团-B11月19日主力净流入0.0万元 散户资金抛售","url":"https://stock-news.laohu8.com/highlight/detail?id=2584906932","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2584906932?lang=zh_cn&edition=full","pubTime":"2025-11-19 16:15","pubTimestamp":1763540153,"startTime":"0","endTime":"0","summary":"11月19日, 创胜集团-B股价涨5.15%，报收2.86元，成交金额149.5万元，换手率0.12%，振幅5.15%，量比0.52。创胜集团-B今日主力资金净流入0.0万元，上一交易日主力净流出0万元。该股近5个交易日上涨2.14%，主力资金累计净流出12.7万元，其中1个交易日为股价下跌时净流入；近20日主力资金累计净流出69.0万元，其中净流出天数为7日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251119162122a4ac4827&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251119162122a4ac4827&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","06628"],"gpt_icon":0},{"id":"2584069649","title":"创胜集团-B盘中异动 急速拉升5.15%报2.860港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2584069649","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2584069649?lang=zh_cn&edition=full","pubTime":"2025-11-19 15:12","pubTimestamp":1763536324,"startTime":"0","endTime":"0","summary":"2025年11月19日下午盘15时12分，创胜集团-B股票出现异动，股价大幅拉升5.15%。截至发稿，该股报2.860港元/股，成交量47万股，换手率0.10%，振幅5.15%。资金方面，该股资金流入84.5625万港元，流出36.5535万港元。创胜集团-B股票所在的生物技术行业中，整体跌幅为1.11%。创胜集团-B公司简介：创胜集团医药有限公司是一家从事临床阶段生物制药的发现、研究、开发、制造和业务拓展的中国投资控股公司。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251119151204a703ab6d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251119151204a703ab6d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","06628"],"gpt_icon":0},{"id":"2584624302","title":"创胜集团-B盘中异动 大幅下挫5.00%","url":"https://stock-news.laohu8.com/highlight/detail?id=2584624302","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2584624302?lang=zh_cn&edition=full","pubTime":"2025-11-17 09:47","pubTimestamp":1763344068,"startTime":"0","endTime":"0","summary":"2025年11月17日早盘09时47分，创胜集团-B股票出现异动，股价大幅下挫5.00%。截至发稿，该股报2.850港元/股，成交量3.6万股，换手率0.01%，振幅2.00%。创胜集团-B股票所在的生物技术行业中，整体跌幅为0.63%。其相关个股中，来凯医药-B、云康集团、永泰生物-B涨幅较大，振幅较大的相关个股有派格生物医药-B、MIRXES-B、来凯医药-B，振幅分别为27.98%、11.60%、10.21%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251117094748a6fe1f39&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251117094748a6fe1f39&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","06628"],"gpt_icon":0},{"id":"2583261682","title":"创胜集团-B盘中异动 临近午盘股价大涨5.90%","url":"https://stock-news.laohu8.com/highlight/detail?id=2583261682","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2583261682?lang=zh_cn&edition=full","pubTime":"2025-11-14 11:33","pubTimestamp":1763091228,"startTime":"0","endTime":"0","summary":"2025年11月14日临近午盘11时33分，创胜集团-B股票出现波动，股价急速拉升5.90%。创胜集团-B股票所在的生物技术行业中，整体涨幅为0.58%。该信息摘要如下：香港联交所最新数据显示，11月12日，董事会主席钱雪明增持创胜集团3.4万股，每股作价2.8581港元，总金额约为9.72万港元。增持后最新持股数目为3800万股，持股比例为8.39%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251114113348a6f87534&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251114113348a6f87534&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","06628"],"gpt_icon":0},{"id":"2583569098","title":"董事会主席钱雪明增持创胜集团(06628)3.4万股 每股作价约2.86港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2583569098","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2583569098?lang=zh_cn&edition=full","pubTime":"2025-11-13 18:59","pubTimestamp":1763031550,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，香港联交所最新数据显示，11月12日，董事会主席钱雪明增持创胜集团(06628)3.4万股，每股作价2.8581港元，总金额约为9.72万港元。增持后最新持股数目为3800万股，持股比例为8.39%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1368929.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1161","06628"],"gpt_icon":0},{"id":"2582202393","title":"创胜集团-B(06628)：委任安永为新任核数师","url":"https://stock-news.laohu8.com/highlight/detail?id=2582202393","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2582202393?lang=zh_cn&edition=full","pubTime":"2025-11-12 19:19","pubTimestamp":1762946363,"startTime":"0","endTime":"0","summary":"智通财经APP讯，创胜集团-B(06628)发布公告，德勤•关黄陈方会计师行(德勤)已辞任公司核数师职务，自2025年11月12日起生效。于德勤辞任后，根据审计委员会的建议，董事会决议委任安永会计师事务所(安永)为公司的新核数师，自2025年11月12日起生效，以填补临时空缺，并任职直至公司下届股东周年大会结束为止。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1368421.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["06628","BK1161"],"gpt_icon":0},{"id":"2583753852","title":"创胜集团-B盘中异动 早盘快速上涨5.00%","url":"https://stock-news.laohu8.com/highlight/detail?id=2583753852","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2583753852?lang=zh_cn&edition=full","pubTime":"2025-11-12 09:47","pubTimestamp":1762912040,"startTime":"0","endTime":"0","summary":"2025年11月12日早盘09时47分，创胜集团-B股票出现波动，股价大幅上涨5.00%。截至发稿，该股报2.940港元/股，成交量13.85万股，换手率0.03%，振幅5.00%。机构评级方面，在所有1家参与评级的机构中，100%的券商给予买入建议，无券商给予持有、卖出建议。创胜集团-B股票所在的生物技术行业中，整体涨幅为2.22%。创胜集团-B公司简介：创胜集团医药有限公司是一家从事临床阶段生物制药的发现、研究、开发、制造和业务拓展的中国投资控股公司。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025111209472094fec1a1&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025111209472094fec1a1&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","06628"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.transcenta.com","stockEarnings":[{"period":"1week","weight":-0.0136},{"period":"1month","weight":-0.1718},{"period":"3month","weight":-0.5283},{"period":"6month","weight":0.4863},{"period":"1year","weight":2.6167},{"period":"ytd","weight":2.4444}],"compareEarnings":[{"period":"1week","weight":0.0137},{"period":"1month","weight":0.004},{"period":"3month","weight":-0.0251},{"period":"6month","weight":0.0632},{"period":"1year","weight":0.2846},{"period":"ytd","weight":0.2871}],"compareStock":{"symbol":"HSI","name":"恒生指数"},"description":"创胜集团医药有限公司是一家从事临床阶段生物制药的发现、研究、开发、制造和业务拓展的投资控股公司。该公司的产品包括MSB2311，TST001，TST005，TST002，TST004，TST003，TST008，MSB0254和TST006。该公司还提供合同开发和生产（CDMO）服务，主要包括工艺开发服务、GMP/cGMP生产服务、细胞株开发服务、样品检测服务、配方优化服务及成药性研究。","yearOnYearQuotes":[{"month":1,"riseRate":0,"avgChangeRate":-0.126953},{"month":2,"riseRate":0.25,"avgChangeRate":0.269631},{"month":3,"riseRate":0.5,"avgChangeRate":-0.019286},{"month":4,"riseRate":0.5,"avgChangeRate":0.078264},{"month":5,"riseRate":0.5,"avgChangeRate":0.094228},{"month":6,"riseRate":0,"avgChangeRate":-0.103826},{"month":7,"riseRate":0.25,"avgChangeRate":0.319041},{"month":8,"riseRate":0.25,"avgChangeRate":-0.088571},{"month":9,"riseRate":0.5,"avgChangeRate":0.077791},{"month":10,"riseRate":0.2,"avgChangeRate":-0.134792},{"month":11,"riseRate":0,"avgChangeRate":-0.134628},{"month":12,"riseRate":0.2,"avgChangeRate":-0.08316}],"exchange":"SEHK","name":"创胜集团-B","nameEN":"TRANSCENTA-B"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.35.12","shortVersion":"4.35.12","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"创胜集团-B(06628)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供创胜集团-B(06628)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"创胜集团-B,06628,创胜集团-B股票,创胜集团-B股票老虎,创胜集团-B股票老虎国际,创胜集团-B行情,创胜集团-B股票行情,创胜集团-B股价,创胜集团-B股市,创胜集团-B股票价格,创胜集团-B股票交易,创胜集团-B股票购买,创胜集团-B股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"创胜集团-B(06628)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供创胜集团-B(06628)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}